Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
15.06
-0.06 (-0.40%)
Apr 2, 2026, 4:00 PM EDT - Market closed
Olema Pharmaceuticals Market Cap
Olema Pharmaceuticals has a market cap or net worth of $1.31 billion as of April 2, 2026. Its market cap has increased by 367.36% in one year.
Market Cap
1.31B
Enterprise Value
811.34M
1-Year Change
367.36%
Ranking
Category
Stock Price
$15.06
Market Cap Chart
Since the IPO on November 19, 2020, Olema Pharmaceuticals's market cap has decreased from $1.79B to $1.31B, a decrease of -26.86%. That is a compound annual growth rate of -5.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 1.31B | -33.25% |
| Dec 31, 2025 | 1.97B | 357.26% |
| Dec 31, 2024 | 430.06M | -43.88% |
| Dec 29, 2023 | 766.34M | 679.84% |
| Dec 30, 2022 | 98.27M | -73.58% |
| Dec 31, 2021 | 372.01M | -79.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bicara Therapeutics | 1.41B |
| Precigen | 1.39B |
| Immatics | 1.39B |
| AtaiBeckley | 1.38B |
| Wave Life Sciences | 1.37B |
| Monte Rosa Therapeutics | 1.37B |
| Zenas BioPharma | 1.28B |
| Taysha Gene Therapies | 1.26B |